BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27177242)

  • 1. Adipose‑derived mesenchymal stem cell‑facilitated TRAIL expression in melanoma treatment in vitro.
    Jing HX; Duan de J; Zhou H; Hu QM; Lei TC
    Mol Med Rep; 2016 Jul; 14(1):195-201. PubMed ID: 27177242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma.
    Bahrambeigi V; Ahmadi N; Moisyadi S; Urschitz J; Salehi R; Haghjooy Javanmard S
    Mol Cancer; 2014 Nov; 13():255. PubMed ID: 25428727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells.
    Moniri MR; Sun XY; Rayat J; Dai D; Ao Z; He Z; Verchere CB; Dai LJ; Warnock GL
    Cancer Gene Ther; 2012 Sep; 19(9):652-8. PubMed ID: 22767216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand.
    Fecker LF; Rückert S; Kurbanov BM; Schmude M; Stockfleth E; Fechner H; Eberle J
    Hum Gene Ther; 2011 Apr; 22(4):405-17. PubMed ID: 20977303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.
    Guiho R; Biteau K; Grisendi G; Taurelle J; Chatelais M; Gantier M; Heymann D; Dominici M; Redini F
    Int J Cancer; 2016 Dec; 139(12):2802-2811. PubMed ID: 27558972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
    Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M
    J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β.
    Yoon N; Park MS; Shigemoto T; Peltier G; Lee RH
    Cell Death Dis; 2016 Apr; 7(4):e2191. PubMed ID: 27077807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted TRAIL gene-modified adipose-derived stem cells exhibited potent tumor-suppressive effect in hepatocellular carcinoma cells.
    Liu Z; Li S; Ma T; Zeng J; Zhou X; Li H; Tang M; Liu X; Li F; Jiang B; Zhao M; Chen Y
    Immun Inflamm Dis; 2021 Mar; 9(1):144-156. PubMed ID: 33156578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical cord‑derived mesenchymal stem cells can inhibit the biological functions of melanoma A375 cells.
    Wang W; Li L; Chen F; Yang Y
    Oncol Rep; 2018 Jul; 40(1):511-517. PubMed ID: 29767256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of TRAIL by osteoblastic differentiated dental pulp stem cells affects myeloma cell viability.
    Brunetti G; Di Benedetto A; Posa F; Colaianni G; Faienza MF; Ballini A; Colucci S; Passeri G; Lo Muzio L; Grano M; Mori G
    Oncol Rep; 2018 Apr; 39(4):2031-2039. PubMed ID: 29484421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells engineered by modified polyethylenimine polymer for targeted cancer gene therapy, in vitro and in vivo.
    Salmasi Z; Hashemi M; Mahdipour E; Nourani H; Abnous K; Ramezani M
    Biotechnol Prog; 2020 Nov; 36(6):e3025. PubMed ID: 32410328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration of Adipose-derived Mesenchymal Stem Cells Stably Expressing Chondroitinase ABC In vitro.
    Wu JH; Li M; Liang Y; Lu T; Duan CY
    Chin Med J (Engl); 2016 Jul; 129(13):1592-9. PubMed ID: 27364797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
    Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
    Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
    Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A therapeutic strategy for metastatic malignant fibrous histiocytoma through mesenchymal stromal cell-mediated TRAIL production.
    Lee HJ; Yang HM; Choi YS; Park SH; Moon SH; Lee YS; Sung YC; Kim SJ
    Ann Surg; 2013 May; 257(5):952-60. PubMed ID: 23108118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft.
    Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L
    J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-7 suppresses the cytotoxicity of TRAIL-expressing mesenchymal stem cells in H460 human non-small cell lung cancer cells.
    Xia P; Wang W; Bai Y
    Apoptosis; 2014 Mar; 19(3):491-505. PubMed ID: 24242915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.